Abstract
Prostate-specific membrane antigen (PSMA)-PET/CT as an emerging modality in molecular imaging will lead to earlier detection and localization of relapse in prostate cancer but will undoubtedly also lead to false-positive findings, as it becomes clear that this new tracer is not as specific as its name would suggest. In this context, we present a case of a large PSMA-expressing schwannoma, a rare nerve sheath tumor mimicking paraesophageal lymph node metastasis in a patient with a history of prostate cancer and biochemical recurrence.
MeSH terms
-
Antigens, Surface / metabolism*
-
Diagnosis, Differential
-
Edetic Acid / analogs & derivatives*
-
Esophageal Neoplasms / diagnostic imaging*
-
Esophageal Neoplasms / metabolism
-
Esophageal Neoplasms / pathology
-
Gallium Isotopes
-
Gallium Radioisotopes
-
Gene Expression Regulation, Neoplastic*
-
Glutamate Carboxypeptidase II / metabolism*
-
Humans
-
Lymphatic Metastasis
-
Male
-
Middle Aged
-
Neurilemmoma / diagnostic imaging*
-
Neurilemmoma / metabolism
-
Neurilemmoma / pathology
-
Oligopeptides*
-
Positron Emission Tomography Computed Tomography*
-
Prostatic Neoplasms / pathology*
-
Recurrence
Substances
-
Antigens, Surface
-
Gallium Isotopes
-
Gallium Radioisotopes
-
Oligopeptides
-
gallium 68 PSMA-11
-
Edetic Acid
-
FOLH1 protein, human
-
Glutamate Carboxypeptidase II